Clinical Trial Update: Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668) [Phase 2]

View source ↗

Summary

Phase 2 maintenance study with re-induction therapy for Crohn's disease patients who did not respond in the prior trial (NCT00291668). Results posted November 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: UCB Pharma | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2009-11-10